awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38010797-D9BC85F5-0F3A-4E03-BE70-385B112CF955
Q38010797-D9BC85F5-0F3A-4E03-BE70-385B112CF955
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38010797-D9BC85F5-0F3A-4E03-BE70-385B112CF955
Bevacizumab: overview of the literature.
P2860
Q38010797-D9BC85F5-0F3A-4E03-BE70-385B112CF955
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38010797-D9BC85F5-0F3A-4E03-BE70-385B112CF955
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d2cfb17142ec5812afb549d6a285386dd0e7d96
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.